Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The work expects to focus on practical use cases that are intended to simplify processes.
October 6, 2026
By: Patrick Lavery
Editor’s Take: Cognizant has supported Gilead’s global IT infrastructure for more than a decade, an effort that will continue here.
Cognizant extended its work with Gilead Sciences for five years, and will continue evolving Gilead’s development and operations (DevOps) capabilities. An AI builder and technology services provider, Cognizant bridges AI investment and enterprise value with full-stack AI solutions for clients.
More specifically, Cognizant plans to promote the responsible application of agentic AI tools across certain technology programs. Using its life sciences and technology experience, Cognizant will focus on various practical use cases. These, ideally, will simplify processes, improve delivery, and assist Gilead teams in efficiently executing priority technology programs.
For more than a decade, Cognizant says, it has supported Gilead’s global IT infrastructure, platforms, applications, and advanced analytics. Now, the extension of its partnership provides additional support for DevOps and AI-enabled capabilities.
Gilead, meanwhile, seeks to strengthen the technology foundations underpinning its priorities both in science and in business.
“Our focus is on giving our teams reliable, efficient technology,” Gilead Global Chief Information Officer Anna Berg Asberg said. “This agreement provides additional support as we strengthen our DevOps capabilities and evaluate practical, responsible uses of AI.”
Mohammed Haque, Cognizant Global Head of Intelligent Enterprise Platforms & Large Deals, says the agreement lets Cognizant showcase its skills.
“We value the opportunity to continue supporting Gilead’s technology priorities,” said Surya Gummadi, President, Americas, Cognizant. “Our work will bring together life sciences experience, DevOps capabilities, and AI tools to help Gilead improve delivery.”
Contract Pharma last reported on the Cognizant–Gilead partnership in January 2025. At that time, Cognizant announced an extension of the collaboration aimed at delivering greater cost leadership and productivity enhancement.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !